GeoVax to collaborate with Georgia State on development of hepatitis B therapeutic vaccine

(Georgia State University) The Georgia State University Research Foundation has entered into a research collaboration agreement with GeoVax Labs, Inc., a Georgia-based biotechnology company developing human vaccines, to advance development of a therapeutic vaccine for treatment of chronic hepatitis B infections.